September 10, 2014
AUSTIN, Texas – (September 10, 2014) – CureSearch for Children’s Cancer is proud to announce a $10,000 Clinical Trial Advancement Award to the Children’s Blood & Cancer Center (CBCC) at Dell Children’s Medical Center of Central Texas to help enroll pediatric cancer patients into clinical trials.
These funds support Dell Children’s institutional commitment and efforts to administer clinical trials for every qualified pediatric cancer patient at a time when diminished federal resources have curtailed these efforts.
“By offering clinical trials to CBCC patients, they will receive the best treatment protocols that will give them their greatest shot at becoming strong cancer survivors,” says Dr. Sharon Lockhart, Clinical Research Director of the CBCC. “This important research leads to improved protocols and new treatments for cancer, which improves patient survival and cure rates. A child’s participation in a clinical trial today helps children who will be diagnosed with cancer in the future—just like our patients are benefiting today from all the brave battles fought in the past.”
Clinical trials offer widespread impact for families whose child’s participation in research promises a better chance for survival. Ultimately clinical trials represent the point at which scientific advances reach people, saving lives and changing the odds for kids now, and far into the future.
“CureSearch is proud to support clinical trials that show promise in making a difference for children with cancer, today,” says Laura Thrall, CEO of CureSearch for Children’s Cancer. “60 percent of children who undergo treatment for cancer participate in some form of clinical trial. CureSearch believes that clinical trials represent the point at which scientific advances reach people, saving lives and changing the odds for kids now, and far into the future.”
CureSearch and the CBCC strongly believe that clinical trials are essential to helping children with cancer today. Less than five percent of adults with cancer are enrolled in clinical trials. Yet for children with cancer, more than 60 percent participate in some form of clinical trial. In 2013, CureSearch supported 78 hospitals, including Dell Children’s, through their Children’s Cancer Clinical Trial Advancement Awards Program.
CureSearch for Children’s Cancer is a national non-profit foundation whose mission is to fund and support children’s cancer research and provide information and resources to all those affected by children’s cancer. CureSearch raises funds for promising research conducted at more than 78 hospitals in the United States, participating in collaborative clinical trials. Through the CureSearch Acceleration Initiative and Young Investigator Program, CureSearch also funds basic and translational research that offers the greatest potential to design treatments and improve outcomes for children with difficult-to-treat cancers. Visit www.CureSearch.org for more information.
ABOUT THE CHILDREN’S BLOOD & CANCER CENTER AT DELL CHILDREN’S
The Children’s Blood & Cancer Center is a department of the Dell Children’s Medical Center of Central Texas, member of the Seton Healthcare Family, and exists to cure and prevent childhood and adolescent cancer and blood disorders. The center is dedicated to enhancing the quality of life for each child and adolescent served through individualized treatment, compassionate care and research.